Candida infection of the central nervous system following neurosurgery: a 12-year review.
Stevens, Niall T
Lim, Chor Hiang
O'Brien, Donncha F
AffiliationDepartment of Clinical Microbiology, Beaumont Hospital, Dublin 9, Ireland, email@example.com.
MetadataShow full item record
CitationCandida infection of the central nervous system following neurosurgery: a 12-year review. 2011, 153 (6):1347-50 Acta Neurochir (Wien)
AbstractCandida infection of the central nervous system (CNS) following neurosurgery is relatively unusual but is associated with significant morbidity and mortality. We present our experience with this infection in adults and discuss clinical characteristics, treatment options, and outcome.
All episodes of Candida isolated from the central nervous system were identified by searching our laboratory database. Review of the cases was performed by means of a retrospective chart review.
Eleven episodes of Candida CSF infection following neurosurgery were identified over a 12-year period. Candida albicans was the predominant species isolated (n = 8, 73%). All infections were associated with foreign intracranial material, nine with external ventricular drains (82%), one with a ventriculoperitoneal shunt, one with a lumbar drain, and one with Gliadel wafers (1,3-bis [2-chloroethyl]-1-nitrosurea). Fluconazole or liposomal amphotericin B were the most common anti-fungal agents used. The mortality rate identified in our series was 27%.
Candida infection following neurosurgery remains a relatively rare occurrence but one that causes significant mortality. These are complex infections, the management of which benefits from a close liaison between the clinical microbiologist and neurosurgeon. Prompt initiation of antifungal agents and removal of infected devices offers the best hope of a cure.
- Clinical significance of Candida species isolated from cerebrospinal fluid following neurosurgery.
- Authors: Geers TA, Gordon SM
- Issue date: 1999 May
- Candidemia at selected Canadian sites: results from the Fungal Disease Registry, 1992-1994. Fungal Disease Registry of the Canadian Infectious Disease Society.
- Authors: Yamamura DL, Rotstein C, Nicolle LE, Ioannou S
- Issue date: 1999 Feb 23
- Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry.
- Authors: Horn DL, Neofytos D, Anaissie EJ, Fishman JA, Steinbach WJ, Olyaei AJ, Marr KA, Pfaller MA, Chang CH, Webster KM
- Issue date: 2009 Jun 15
- Risk factors for candidemia-related mortality at a medical center in central Taiwan.
- Authors: Cheng YR, Lin LC, Young TG, Liu CE, Chen CH, Tsay RW
- Issue date: 2006 Apr
- Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observational study in France (2005-2006).
- Authors: Leroy O, Gangneux JP, Montravers P, Mira JP, Gouin F, Sollet JP, Carlet J, Reynes J, Rosenheim M, Regnier B, Lortholary O, AmarCand Study Group.
- Issue date: 2009 May